Background
==========

We have previously shown that NK cells preferentially target cancer stem cells (CSCs) in diverse human solid malignancies and that radiotherapy (RT) enhances NK targeting of CSCs in an NKG2D-dependent manner. We hypothesized that dog PBMC-derived NK cells could be similarly expanded and activated ex vivo for combination radioimmunotherapy in canine models of sarcoma.

Methods
=======

Dog NK cells were isolated from fresh PBMCs using Ficoll separation and CD5 depletion. Isolated NK cells (CD3+, CD5dim, TCR-) were expanded via co-culture with irradiated (100Gy) K562-C9-mIL-21 for 2-3 weeks in 100IU/mL recombinant human IL-2. Canine osteosarcoma (OSCA) tumor lines and fresh canine primary sarcomas were evaluated for susceptibility to NK killing before/after RT *in vitro* and in xenograft experiments with NSG mice. NK cytotoxicity was assessed in 4-16 hour killing assays by Flow cytometry using a BD Fortessa cell sorter (BD Biosciences) with 7-Aminoactinomycin as cell viability marker.

Results
=======

NK expansion was successful in 14/20 donors (including 9 tumor-bearing dogs) from baseline 4.5(±1.9) ×10^6^ cells to 103.5(±29.1) ×10^6^, mean increase 23.2X (±2.3). Canine NK cells were also responsive to human cytokines (IL-2, IL-12, and IL-18), but expansions were lower (1.6-3.5 fold expansion over 14 days). NK cytotoxicity to OSCA78, OSCA23, and NK-sensitive CTAC cells *in vitro* increased in a dose-dependent fashion reaching 74 -- 88% cytolysis at effector:target ratios of 10:1 -- 20:1 (P \< 0.001). RT augmented NK cytotoxicity with greatest synergy at 2.5-5 Gy RT in 4-hour killing assays (1.3-3.4X increased killing, P \< 0.01). At doses of 10 Gy and/or16-hour killing assays, only minor differences in overall killing were observed. Similar results were observed with RT sensitization to NK killing in primary canine sarcomas. In a dog sarcoma PDX model using focal RT, intravenous NK transfer, and hydrodynamic human IL-15 for *in vivo* NK support, focal RT increased NK homing to tumors by 3.8X±0.3 (P \< 0.001).

Conclusions
===========

RT enhances NK homing and killing in canine models of STS. Dog STS appears to be a valuable model to facilitate clinical translation of NK radioimmunotherapy.
